Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: A comparative study

American Journal of Hematology

Volumn 81, Issue 10, 2006, Pages 753-759

  Pamuk, Gülsüm Emel ^a,b   Vural, Özden ^a   Turgut, Burhan ^a   Demir, Muzaffer ^a   Ümit, Hasan ^a   Tezel, Ahmet ^a  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

CD40 ligand; P selectin; Platelet monocyte complexes; Platelet neutrophil complexes; Ulcerative colitis

Indexed keywords

CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; COLITIS, ULCERATIVE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PLATELET ACTIVATION; SEVERITY OF ILLNESS INDEX;

EID: 33749539332     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20655     Document Type: Article

References (34)

1. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004;99:97-101.
2. Danese S, de la Motte C, Fiocchi C. Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 2004;99:938-945.
3. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost 2001;85:430-434.
4. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994;106:840-845.
5. Vrij AA, Rijken J, Van Wersch JW, Stockbrugger RW. Platelet factor 4 and β-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest 2000;30:188-194.
6. de Maat MP, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moller L, Jespersen J. Inflammation, thrombosis and atherosclerosis: Results of the Glostrup study. J Thromb Haemost 2003;1:950-957.
7. Mannaioni PF, di Bello MG, Masini E. Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997;46:4-18.
8. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.
9. Andre P. P-selectin in haemostasis. Br J Haematol 2004;126:298-306.
10. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004;14:18-22.
11. Danese S, Katz JA, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003;52:1435-1441.
12. Andoh A, Tsujikawa T, Hata K, et al. Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease. Am J Gastroenterol 2005;100:2042-2048.
13. Davis C, Fischer J, Ley K, Sarembock IJ. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003;1:1699-1709.
14. Rachmilewitz D on behalf of aninternational study group. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A Randomized Trial. BMJ 1989;298:82-86.
15. Hanai H, Watanabe F, Yamada M, et al. Correlation of serum soluble TNF-α receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol 2004;99:1532-1538.
16. Krueger LA, Barnard MR, Frelinger AL, Furman MI, Michelson AD. Immunophenotypic Analysis of Platelets. In: Robinson JP, Darzynkiewicz Z, Dean PN, Dresiler LG, Rabinovitch PS, Stewart CC, Tanke HJ, Wheeless MC, editors. Current Protocols in Cytometry, 1st ed. New York: Wiley; 1997. pp 6.10.1-6.10.17.
17. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001;115:451-459.
18. Villmow T, Kemkes-Matthes B, Matzdorff AC. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Res 2002;108:139-145.
19. Kaplan R, Gabbeta J, Sun L, Mao GF, Rao AK. Combined defect in membrane expression and activation of platelet GPIIb-IIIa complex without primary sequence abnormalities in myeloproliferative disease. Br J Haematol 2000;111:954-964.
20. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-1537.
21. McCabe DJ, Harrison P, Mackie IJ, et al. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004;125:777-787.
22. Knijff-Dutmer EA, Koerts J, Nieuwland R, Kalsbeek-Batenburg EM, van de Laar MA. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 2002;46:1498-1503.
23. Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000;95:1317-1323.
24. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-646.
25. Combes V, Joly P, Ambrosi P, Sabatier F, Camoin L, Pili J, Sampol J, Dignat-George F. Platelet vesiculation in angina patients treated with coronary angioplasty. Thromb Haemost 2000;83:518.
26. Collins CE, Rampton DS, Rogers J, Williams NS. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997;9:1213-1217.
27. Dhillon AP, Anthony A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992;21:127-133.
28. Holme PA, Solum NO, Brosstad F, Pedersen T, Kveine M. Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets. Thromb Haemost 1998;79:389-394.
29. Stuber E, Strober W, Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996;183:693-698.
30. Freedman JE. CD40-CD40L and platelet function: Beyond hemostasis. Circ Res 2003;92:944-946.
31. Bhatti M, Chapman P, Peters M, Haskard D, Hodgson HJ. Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut 1998;43:40-47.
32. Vrij AA, Rijken J, van Wersch JWJ, Stockbrugger RW. Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteriitis. Pathophysiol Haemost Thromb 2003;33:75-83.
33. Novecak G, Kapiotis S, Moser G, Speiser W, Gangl A, Vogelsang H. No evidence of activated blood coagulation in Crohn's disease. Eur J Gastroenterol Hepatol 1997;9:963-967.
34. Carty E, MacEy M, Rampton DS. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther 2000;14:1169-1179.